SEC Form 4 · accession 0001127602-18-021568
PDS Biotechnology Corp · PDSB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Herbert J Faleck
Officer — Chief Medical Officer
Period of report
Jun 19, 2018
Accepted (ET)
Jun 20, 2018 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001472091
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right To Purchase)F1,F2 | $1.10 | Jun 19, 2018 | A | 119,667 | A | — | — | Common Stock | 119,667 | 119,667 | D |
Explanation of responses
- F1These options shall become exercisable upon the achievement of certain performance or time based criteria.
- F2These options expire on the third anniversary of the vesting date.